Financhill
Back

SpringWorks Therapeutics 10K Form

Buy
72

SWTX
SpringWorks Therapeutics

Last Price:
43.14
Seasonality Move:
7.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SWTX News And Ratings

See the #1 stock for the next 7 days that we like better than SWTX

SWTX Financial Statistics

Sales & Book Value

Annual Sales: $5.45M
Cash Flow: $-60.4M
Price / Cash Flow: 0
Annual Sales: $8.52
Price / Book: 5.18

Profitability

EPS (TTM): -5.15000
Net Income (TTM): $-325.1M
Gross Margin: $5.03M
Return on Equity: -64.06%
Return on Assets: -55.86%

SpringWorks Therapeutics Earnings Forecast

Key SpringWorks Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 3 years for SWTX is 92.25%.
  • The Selling, General & Administrative Expenses for SWTX have been equal to 3,626.79% of Gross Profit Margin.
  • The Research & Development expenses have been 2,762.75% of Revenue.
  • The Net Earning history of SWTX is -5,968.50% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

SpringWorks Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SWTX
CUSIP: 85205L
Website: springworkstx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.41
Quick Ratio: 6.21

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SWTX Technical Analysis vs Fundamental Analysis

Buy
72
SpringWorks Therapeutics (SWTX) is a Buy

Is SpringWorks Therapeutics a Buy or a Sell?